Е. V. Raykina

Publications by Year

Research Areas

Immunodeficiency and Autoimmune Disorders, Blood disorders and treatments, Autoimmune and Inflammatory Disorders Research, Blood groups and transfusion, Histiocytic Disorders and Treatments

Most-Cited Works

• → Risk Factors for and the Clinical Impact of Cytomegalovirus and Epstein-Barr Virus Infections in Pediatric Recipients of TCR-α/β– and CD19-Depleted Grafts(2016)66 cited
• → Relative expansion of CD19‐negative very‐early normal B‐cell precursors in children with acute lymphoblastic leukaemia after CD19 targeting by blinatumomab and CAR‐T cell therapy: implications for flow cytometric detection of minimal residual disease(2021)39 cited
• → Vemurafenib provides a rapid and robust clinical response in pediatric Langerhans cell histiocytosis with the BRAF V600E mutation but does not eliminate low-level minimal residual disease per ddPCR using cell-free circulating DNA(2021)27 cited
• → Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E–positive LCH(2023)26 cited
• → Clinical and functional spectrum of RAC2-related immunodeficiency(2024)23 cited
• → The Clinical and Genetic Spectrum of 82 Patients With RAG Deficiency Including a c.256_257delAA Founder Variant in Slavic Countries(2020)19 cited
• → Comparison of disease phenotypes and mechanistic insight on causal variants in patients with DADA2(2023)17 cited
• → Chimerism evaluation in measurable residual disease‐suspected cells isolated by flow cell sorting as a reliable tool for measurable residual disease verification in acute leukemia patients after allogeneic hematopoietic stem cell transplantation(2020)13 cited
• → Novel hemizygous CORO1A variant leads to combined immunodeficiency with defective platelet calcium signaling and cell mobility(2023)7 cited
• → Development of flow cytometry assay for Wiskott–Aldrich syndrome diagnosis by WASP protein evaluation(2020)4 cited